Literature DB >> 27888769

A first described case of cancer-associated non-bacterial thrombotic endocarditis in the era of direct oral anticoagulants.

F Mantovani1, A Navazio2, A Barbieri3, G Boriani3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27888769     DOI: 10.1016/j.thromres.2016.11.016

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  6 in total

1.  A rare case of metastatic pancreatic adenocarcinoma presenting as a pulmonary embolism from nonbacterial thrombotic endocarditis.

Authors:  Brooke Kania; Erinie Mekheal; Sindhusha Veeraballi; Leena Bondili; Michael Maroules
Journal:  Radiol Case Rep       Date:  2022-06-24

2.  Severe Aortic Regurgitation by Nonbacterial Thrombotic Endocarditis Treated with Anticoagulation Therapy.

Authors:  Azusa Murata; Nobuyuki Kagiyama; Sakiko Miyazaki; Tomohiro Kaneko; Naoko Shimada; Youichiro Mitsuishi; Tohru Minamino
Journal:  CASE (Phila)       Date:  2022-05-20

3.  Marantic endocarditis: incidental infarcts leading to diagnosis of pancreatic cancer.

Authors:  Ella Starobinska; Eric A Robinson; Eric Brucks; Serena Scott
Journal:  BMJ Case Rep       Date:  2018-06-12

4.  Treatment with a Direct Oral Anticoagulant for Nonbacterial Thrombotic Endocarditis.

Authors:  Yudai Tamura; Kenji Sakata; Kazushi Terada; Soichiro Usui; Masa-Aki Kawashiri; Masayuki Takamura
Journal:  Intern Med       Date:  2021-01-15       Impact factor: 1.271

Review 5.  The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues.

Authors:  Elena Campello; Anton Ilich; Paolo Simioni; Nigel S Key
Journal:  Br J Cancer       Date:  2019-07-22       Impact factor: 7.640

6.  Stroke in malignancy: complexities of diagnosis and management: a case report.

Authors:  Pakeeran Siriratnam; Thomas Kraemer; Ramesh Sahathevan
Journal:  J Med Case Rep       Date:  2019-08-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.